Molecule Details
InChIKeyCMWTZPSULFXXJA-VIFPVBQESA-N
Compound NameNaproxen
Canonical SMILESCOc1ccc2cc([C@H](C)C(=O)O)ccc2c1
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)3
Pfam Stratification Cross-Family
Avg pChEMBL6.42
SourceChEMBL;BindingDB
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB00788
Drug NameNaproxen
CAS Number22204-53-1
Groups approved investigational vet_approved
ATC Codes M01AE02 M01AE57 G02CC02 M02AA12 M01AE56 M01AE52 N02CC51
DescriptionNaproxen is classified as a nonsteroidal anti-inflammatory dug (NSAID) and was initially approved for prescription use in 1976 and then for over-the-counter (OTC) use in 1994.[A178975] It can effectively manage acute pain as well as pain related to rheumatic diseases, and has a well studied adverse ...

Categories: Agents causing hyperkalemia Agents that produce hypertension Analgesics Analgesics, Non-Narcotic Anti-Inflammatory Agents Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Non-Steroidal (Non-Selective) Antigout Preparations Antiinflammatory Preparations, Non-Steroids for Topical Use Antiinflammatory Products for Vaginal Administration Antiinflammatory and Antirheumatic Products Antiinflammatory and Antirheumatic Products, Non-Steroids Antimigraine Preparations Antirheumatic Agents Arylpropionic acid NSAIDS BSEP/ABCB11 Substrates Central Nervous System Agents Cyclooxygenase Inhibitors Cytochrome P-450 CYP1A2 Substrates Cytochrome P-450 CYP2C8 Substrates Cytochrome P-450 CYP2C9 Substrates Cytochrome P-450 Substrates Drugs causing inadvertant photosensitivity Enzyme Inhibitors Genito Urinary System and Sex Hormones Musculo-Skeletal System Naphthaleneacetic Acids Naphthalenes Nephrotoxic agents Nervous System Non COX-2 selective NSAIDS OAT1/SLC22A6 inhibitors Other Nonsteroidal Anti-inflammatory Agents P-glycoprotein inhibitors Peripheral Nervous System Agents Photosensitizing Agents Propionates Sensory System Agents Topical Products for Joint and Muscular Pain UGT1A1 Substrates UGT1A3 substrates UGT1A6 substrate UGT1A9 Substrates UGT2B7 substrates
Cross-references: BindingDB: 50339185 ChEBI: 7476 CHEMBL154 ChemSpider: 137720 Drugs Product Database (DPD): 2037 C01517 D00118 PDB: NPS PharmGKB: PA450595 PubChem:156391 PubChem:46505508 RxCUI: 7258 Therapeutic Targets Database: DAP000968 Wikipedia: Naproxen ZINC: ZINC000000105216
Target Activities (3)
Target Gene Organism Category Pfam pChEMBL Type Source
P42330 AKR1C3 Homo sapiens Human PF00248 6.7 IC50 ChEMBL;BindingDB
P23219 PTGS1 Homo sapiens Human PF03098 6.5 IC50 ChEMBL;BindingDB
P35354 PTGS2 Homo sapiens Human PF03098 6.0 IC50 ChEMBL;BindingDB
DrugBank Target Actions (20)
Target Gene Target Name Action Type
P02768 ALB Albumin binder carriers
O60656 O60656 UDP-glucuronosyltransferase 1A9 substrate enzymes
P05177 CYP1A2 Cytochrome P450 1A2 substrate enzymes
P10632 CYP2C8 Cytochrome P450 2C8 substrate enzymes
P11712 CYP2C9 Cytochrome P450 2C9 substrate enzymes
P16662 UGT2B7 UDP-glucuronosyltransferase 2B7 substrate enzymes
P19224 UGT1A6 UDP-glucuronosyltransferase 1A6 substrate enzymes
P35503 P35503 UDP-glucuronosyltransferase 1A3 substrate enzymes
Q9HAW7 Q9HAW7 UDP-glucuronosyltransferase 1A7 substrate enzymes
Q9HAW8 Q9HAW8 UDP-glucuronosyltransferase 1A10 substrate enzymes
Q9HAW9 Q9HAW9 UDP-glucuronosyltransferase 1A8 substrate enzymes
Q51911 Q51911 Peptostreptococcal albumin-binding protein binder targets
P16233 PNLIP Pancreatic triacylglycerol lipase inhibitor targets
P23219 PTGS1 Prostaglandin G/H synthase 1 inhibitor targets
P35354 PTGS2 Prostaglandin G/H synthase 2 inhibitor targets
Q8TCC7 SLC22A8 Organic anion transporter 3 binder transporters
P08183 ABCB1 ATP-dependent translocase ABCB1 inhibitor transporters
P46721 P46721 Solute carrier organic anion transporter family member 1A2 inhibitor transporters
Q4U2R8 SLC22A6 Solute carrier family 22 member 6 inhibitor transporters
O95342 ABCB11 Bile salt export pump substrate transporters